24
19
1
49
2
2
2c
1b
1d
18
37
8c
1d
2 29
1d
25
Yehoda M Martei, MD, MSCE
78
8c
Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
7
5f
Department: Medicine
4
1
b
1d
46
Contact information
60
4
3
3
1d
60
3400 Civic Center Blvd.
Philadelphia, PA 19104
26
Philadelphia, PA 19104
35
f
18
Publications
23 a
3
2
29
23 a
Links
ac Search PubMed for articles
d
4
b
1f
ac Search PubMed for articles
d
13
Education:
21 7 BA 14 (Biology) c
2b Harvard University, 2005.
21 7 MD 15 (Medicine) c
3b Yale University School of Medicine, 2011.
21 9 MSCE 22 (Clinical Epidemiology) c
33 University of Pennsylvania, 2018.
c
3
3
3
3
8d
Permanent link21 7 BA 14 (Biology) c
2b Harvard University, 2005.
21 7 MD 15 (Medicine) c
3b Yale University School of Medicine, 2011.
21 9 MSCE 22 (Clinical Epidemiology) c
33 University of Pennsylvania, 2018.
c
2 29
21
1e
1d
24
2b
29
27
23
185 Martei YM, Gurram M, Mokokwe LT, Ngwako N, Kebuang K, Setlhako DI, Vuylsteke P, Bontswanetse B, Segadimo T, Mosepele M, Shulman LN, Barg F, Gaolebale BE: Baseline Distress and Effectiveness of Survivor Video Narratives on Cancer-Associated Distress in Botswana: A Pilot Study. JCO Glob Oncol 11: e2400474, June 2025.
148 Gupta V, Satlin MJ, Yu KC, Martei Y, Sung L, Westblade LF, Howard S, Ai C, Flayhart DC.: Incidence and prevalence of antimicrobial resistance in outpatients with cancer: a multicentre, retrospective, cohort study. Lancet Oncology 26(5): 00128-7, May 2025.
152 Sallah YH, Bratti VF, Rafinejad-Farahani B, Jayasekar Zurn S, Johnson S, Crestani AS, Dacoregio MI, Majeed H, Fazelzad R, Pabani A, Wilson BE, Favorito FM, de Moraes FY, Sung L, Martei YM, Rodin D.: Antimicrobial resistance in patients with haematological malignancies:a scoping review. 41 Lancet Oncol 26(5): e242-e252, May 2025.
d0 Martei,YM: “The Invisible Second Threat to Cancer Patients – Drug-Resistant Infections” One Health Trust Podcast Interview 2025.
bd Martei YM: “Oncologists need to see antimicrobial resistance as a cancer care delivery crisis.” STAT News 2025.
133 Gupta V, Satlin MJ, Yu K, Martei YM, Sung L, Westblade LF, Howard SC, Ai C, Flayhart DC: Burden of Antimicrobial Resistance in Adult Hospitalized Patients With Cancer: A Multicancer Analysis. Cancer Med. 13(24): e70495, December 2024.
11c Diogo de Sousa Neves D, Jayasekar Zürn S, Khuc-Bilon T, Rendler-Garcia M, Martei YM, Krishnamurthy Reddiar S.: The Access to Oncology Medicines Coalition: Enhanced in-Country Coordination for Sustainable Access. Cancer Manag Res 32 16: 1609-1616, November 2024.
10c Castillo BS, Boadi T, Han X, Shulman LN, Martei YM.: Racial Disparities in Receipt of Guideline-Concordant Care in Older Adults With Early Breast Cancer. JAMA Netw Open 7(10): e2441056, Oct 2024.
153 Pain D, MacDuffie E, Martei YM, Kassick M, Ikeda DJ, Shulman LN, Salazar LL, Diaz Pardo D, Nag S, Grover S.: Barriers to Implementing a Quality Improvement Program in Low- and Middle-Income Countries: Adequacy of Resources. JCO Glob Oncol 10: e2400114, October 2024.
2c
7
1d
1f
Selected Publications
142 Trends in the Use of Hypofractionation in Treatment of Breast Cancer in Botswana: Trends in the Use of Hypofractionation in Treatment of Breast Cancer in Botswana. ASCO Annual Meeting, Chicago, IL June 2025 Notes: "Poster Presentation"185 Martei YM, Gurram M, Mokokwe LT, Ngwako N, Kebuang K, Setlhako DI, Vuylsteke P, Bontswanetse B, Segadimo T, Mosepele M, Shulman LN, Barg F, Gaolebale BE: Baseline Distress and Effectiveness of Survivor Video Narratives on Cancer-Associated Distress in Botswana: A Pilot Study. JCO Glob Oncol 11: e2400474, June 2025.
148 Gupta V, Satlin MJ, Yu KC, Martei Y, Sung L, Westblade LF, Howard S, Ai C, Flayhart DC.: Incidence and prevalence of antimicrobial resistance in outpatients with cancer: a multicentre, retrospective, cohort study. Lancet Oncology 26(5): 00128-7, May 2025.
152 Sallah YH, Bratti VF, Rafinejad-Farahani B, Jayasekar Zurn S, Johnson S, Crestani AS, Dacoregio MI, Majeed H, Fazelzad R, Pabani A, Wilson BE, Favorito FM, de Moraes FY, Sung L, Martei YM, Rodin D.: Antimicrobial resistance in patients with haematological malignancies:a scoping review. 41 Lancet Oncol 26(5): e242-e252, May 2025.
d0 Martei,YM: “The Invisible Second Threat to Cancer Patients – Drug-Resistant Infections” One Health Trust Podcast Interview 2025.
bd Martei YM: “Oncologists need to see antimicrobial resistance as a cancer care delivery crisis.” STAT News 2025.
133 Gupta V, Satlin MJ, Yu K, Martei YM, Sung L, Westblade LF, Howard SC, Ai C, Flayhart DC: Burden of Antimicrobial Resistance in Adult Hospitalized Patients With Cancer: A Multicancer Analysis. Cancer Med. 13(24): e70495, December 2024.
11c Diogo de Sousa Neves D, Jayasekar Zürn S, Khuc-Bilon T, Rendler-Garcia M, Martei YM, Krishnamurthy Reddiar S.: The Access to Oncology Medicines Coalition: Enhanced in-Country Coordination for Sustainable Access. Cancer Manag Res 32 16: 1609-1616, November 2024.
10c Castillo BS, Boadi T, Han X, Shulman LN, Martei YM.: Racial Disparities in Receipt of Guideline-Concordant Care in Older Adults With Early Breast Cancer. JAMA Netw Open 7(10): e2441056, Oct 2024.
153 Pain D, MacDuffie E, Martei YM, Kassick M, Ikeda DJ, Shulman LN, Salazar LL, Diaz Pardo D, Nag S, Grover S.: Barriers to Implementing a Quality Improvement Program in Low- and Middle-Income Countries: Adequacy of Resources. JCO Glob Oncol 10: e2400114, October 2024.
2c
44
23
Back to Top
1b
1d
18